Previous 10 | Next 10 |
Experienced Channel Sales Executive Keri Bolding joins Inseego Inseego Corp. (Nasdaq: INSG), a leader in 5G edge cloud solutions, today announced Keri Bolding has joined the company in the newly-created role of SVP of Global Channel Sales & Distribution. Bolding will oversee the com...
Inseego Corp., a leader in 5G edge cloud solutions, announced the launch of the Inseego Wavemaker™ 5G indoor router FX3100 for T-Mobile for Business customers. This compact, cutting-edge FWA device provides ultra-fast, reliable, and secure connectivity, empowering enterprise customers to s...
2023-11-14 10:56:52 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips These companies in the biotechnology sector are doing incredible work and achieving wonderful developments. The result is not not only growth and profit for the companies, but they are also off...
2023-11-10 00:00:25 ET Image source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q3 2023 Earnings Call Nov 09, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call ...
2023-11-09 19:15:23 ET Inovio Pharmaceuticals, Inc. (INO) Q3 2023 Earnings Conference Call November 09, 2023, 04:30 PM ET Company Participants Thomas Hong - Manager of Investor Relations Jacque Shea - President and Chief Executive Officer Michael Sumner - Chief M...
2023-11-09 18:15:26 ET More on Inovio Pharmaceuticals Inovio Pharmaceuticals H.C. Wainwright 25th Annual Global Investment Conference (Transcript) Inovio Pharmaceuticals: Tightening The Ship, Finding An Inflection Point Inovio Pharmaceuticals Q3 2023 Earnings Preview...
2023-11-09 16:09:06 ET More on Inovio Pharmaceuticals Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 25th Annual Global Investment Conference (Transcript) Inovio Pharmaceuticals: Tightening The Ship, Finding An Inflection Point Inovio Pharmaceuticals Q3 2023 Earn...
INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights PR Newswire Achieved significant progress with lead product candidate, INO-3107 Received Breakthrough Therapy designation from U.S. Food and Drug Administration (FDA) as a potential treatm...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
Inovio Pharmaceuticals Inc. (INO) is expected to report $-0.13 for Q3 2023
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
2024-07-16 13:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises and SMBs, today announced that the company will release its financial results for the second quarter of 2024, ended June 30, 2024, after the financial ...
INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway PR Newswire Award recognizes the potential for INO-3107 to be the first therapeutic option in the United Kingdom for patients suffering from Recurrent Respi...